Structured Summary
Abstract
Compounds that inhibit SODIUM-GLUCOSE TRANSPORTER 2. They lower blood sugar by preventing the reabsorption of glucose by the kidney and are used in the treatment of TYPE 2 DIABETES MELLITUS.
MeSH Record
Classification
Related Concepts
Knowledge Graph
Loading graph…
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
Synonyms
13 entry terms
- Gliflozin
- Gliflozins
- SGLT-2 Inhibitor
- SGLT-2 Inhibitors
- SGLT2 Inhibitor
- SGLT2 Inhibitors
- Sodium-Glucose Transporter 2 Inhibitor
- Inhibitor, SGLT-2
- Inhibitor, SGLT2
- SGLT 2 Inhibitor
- SGLT 2 Inhibitors
- Sodium Glucose Transporter 2 Inhibitor
- Sodium Glucose Transporter 2 Inhibitors
MeSH Record
Aspects Covered
22 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, analysis, blood, cerebrospinal fluid, chemical synthesis, chemistry, classification, economics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, poisoning, radiation effects, standards, supply & distribution, therapeutic use, toxicity, urine.
MeSH Record
History Note
2019
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Sodium-Glucose Transporter 2 Inhibitors. Medical Subject Headings (MeSH). 2026. Unique ID D000077203. http://id.nlm.nih.gov/mesh/2026/D000077203
- Sodium-Glucose Transporter 2 Inhibitors. In: Wikipedia. https://en.wikipedia.org/wiki/SGLT2_inhibitor
- Sodium-Glucose Transporter 2 Inhibitors. In: Wikidata. https://www.wikidata.org/wiki/Q20089925